Evidence map›Paper›PMID 42751358›Full record

ArticleChemical science2026

Accessible hybrid DFT-quality NMR crystallography

Shubha S Gunaga, Robert W Schurko, Sean T Holmes, Frederic Mentink-Vigier

Abstract read
In one paragraph

Article in Chemical science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. NMR crystallography reveals active-site protonation states of Toho-1 β-lactamase in complex with avibactam.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Shubha S GunagaNational High Magnetic Field Laboratory, Florida State University 1800 E. Paul Dirac Dr Tallahassee FL 32310 USA fmentink@fsu.edu.
Robert W SchurkoNational High Magnetic Field Laboratory, Florida State University 1800 E. Paul Dirac Dr Tallahassee FL 32310 USA fmentink@fsu.edu.ORCID https://orcid.org/0000-0002-5093-400X
Sean T HolmesNational High Magnetic Field Laboratory, Florida State University 1800 E. Paul Dirac Dr Tallahassee FL 32310 USA fmentink@fsu.edu.ORCID https://orcid.org/0000-0002-5821-9641
Frederic Mentink-VigierNational High Magnetic Field Laboratory, Florida State University 1800 E. Paul Dirac Dr Tallahassee FL 32310 USA fmentink@fsu.edu.ORCID https://orcid.org/0000-0002-3570-9787

Funding

National Resource for Advanced NMR TechnologyRM1GM148766 · NIGMS · FLORIDA STATE UNIVERSITY · PI William W Brey, Joanna R Long · 2023 to 2026
$4.9M
NIGMS NIH HHS RM1 GM148766
6 · The paper itself

Abstract

Nuclear magnetic resonance (NMR) crystallography is a robust method for structure determination, but its reliance on density functional theory (DFT) calculations for geometry refinement limits its speed and accessibility. Recent machine-learning predictors such as ShiftML3 can evaluate magnetic shieldings in seconds, but still need high-quality crystal geometries that are normally obtained from slow DFT optimisations. Here, we demonstrate that machine learning interatomic potentials (MLIPs) can eliminate this bottleneck for organic crystals. Interestingly, models trained on gas-phase molecules at the hybrid-DFT ωB97M-V level (OMol25 dataset)-such as UMA-omol and MACE-Polar-1-deliver structural quality rivaling hybrid periodic-DFT, without requiring large computational resources. The resulting MLIP/ShiftML3 workflow reduces computational costs by at least three orders of magnitude, making high-accuracy NMR crystallography accessible without HPC infrastructure, and opening the door to fast molecular dynamics simulations at the hybrid DFT level. Combined with sensitivity enhancement

Identifiers

PMID42751358
PMCPMC13579535

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.